logo

Silverback Therapeutics, Inc (SBTX)



Trade SBTX now with
  Date
  Headline
11/12/2021 8:39:53 AM Silverback Therapeutics Presents SBT6050-201 Trial In Progress Poster At Society For Immunotherapy Of Cancer
9/13/2021 8:17:15 AM Silverback Therapeutics To Present Data From Phase 1/1b Clinical Trial Of SBT6050 At ESMO 2021 Virtual Congress
7/7/2021 7:35:43 AM Silverback Therapeutics Signs Clinical Supply Deal With Regeneron To Evaluate SBT6050 With Libtayo
3/15/2021 8:22:59 AM Silverback Therapeutics Appoints Maria Koehler To Board